We wanted to take our shot. It failed: Vivek Ramaswamy after failed Alzheimer’s drug trial.
US-based Roivant Sciences, the biotech company funded by Indian-origin entrepreneur Vivek Ramaswamy, has raised $1.1 billion from Softbank...